IGC Pharma, Inc. (IGC) 

AMEX$0.4337
Market Cap
$33.85M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
253 of 840
Rank in Industry
138 of 479

IGC Insider Trading Activity

IGC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$200,000
1
100
Sells
$0
0
0

Related Transactions

Moran James Pdirector
1
$200,000
0
$0
$200,000

About IGC Pharma, Inc.

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by â€¦

Insider Activity of IGC Pharma, Inc.

Over the last 12 months, insiders at IGC Pharma, Inc. have bought $200,000 and sold $0 worth of IGC Pharma, Inc. stock.

On average, over the past 5 years, insiders at IGC Pharma, Inc. have bought $200,000 and sold $573,529 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Moran James P (director) — $200,000.

The last purchase of 588,235 shares for transaction amount of $200,000 was made by Moran James P (director) on 2024‑09‑25.

List of Insider Buy and Sell Transactions, IGC Pharma, Inc.

2024-09-25PurchaseMoran James Pdirector
588,235
0.7705%
$0.34
$200,000
-1.00%
2021-03-09SalePRINS RICHARD Kdirector
50,000
0.1232%
$1.75
$87,500
-14.53%
2021-03-03SalePRINS RICHARD Kdirector
50,000
0.1217%
$1.80
$90,005
-17.88%
2021-03-02SaleMUKUNDA RAMExec. Chairman & CEO
50,000
0.1328%
$2.14
$107,000
-24.10%
2020-12-01SalePRINS RICHARD Kdirector
50,000
0.1364%
$2.04
$102,000
-12.71%
2020-11-30SaleMUKUNDA RAMExec. Chairman & CEO
80,000
0.1977%
$2.34
$187,024
-31.00%
2018-08-30SaleMUKUNDA RAMExec. Chairman & CEO
50,000
0.1644%
$1.87
$93,260
-32.04%
2018-08-30SaleGRIMALDI CLAUDIAVice President and PFO
116,020
0.409%
$2.00
$232,040
-32.04%
2018-08-28SaleMUKUNDA RAMExec. Chairman & CEO
125,000
0.4012%
$1.33
$166,000
-6.06%
2018-08-27SaleGRIMALDI CLAUDIAVice President and PFO
50,000
0.1154%
$1.10
$55,000
-17.76%
2018-08-27SalePRINS RICHARD Kdirector
50,000
0.1133%
$1.08
$54,000
-17.76%
2018-08-24SaleMUKUNDA RAMExec. Chairman & CEO
25,000
0.0719%
$0.64
$15,993
+76.08%
2018-08-22SaleMUKUNDA RAMExec. Chairman & CEO
50,000
0.157%
$0.50
$25,105
+145.10%
2018-01-12SaleMUKUNDA RAMExec. Chairman & CEO
12,000
0.0418%
$1.05
$12,600
-42.60%
2018-01-11SaleMUKUNDA RAMExec. Chairman & CEO
12,000
0.044%
$1.12
$13,400
-43.13%
2018-01-10SaleMUKUNDA RAMExec. Chairman & CEO
12,000
0.0421%
$1.10
$13,162
-44.64%
2017-12-15SaleMUKUNDA RAMExec. Chairman & CEO
25,000
0.0911%
$0.76
$19,000
-9.46%
2017-12-14SaleMUKUNDA RAMExec. Chairman & CEO
25,000
0.088%
$0.75
$18,750
-11.38%
2017-12-08SaleMUKUNDA RAMExec. Chairman & CEO
54,950
0.2153%
$0.87
$47,609
-13.38%
2017-12-07SaleMUKUNDA RAMExec. Chairman & CEO
100,000
0.3833%
$0.85
$85,300
-13.92%
Total: 176
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Moran James Pdirector
942402
1.2073%
$408,719.7510
MUKUNDA RAMExec. Chairman & CEO
2774760
3.5547%
$1.2M113
KRISHNA RANGA cdirector
1068461
1.3688%
$463,391.54140
+36.33%
Oliveira Steven Michael10 percent owner
772196
0.9892%
$334,901.4115
PRINS RICHARD Kdirector
620000
0.7943%
$268,894.0015
SHENOY SUDHAKAR Vdirector
105000
0.1345%
$45,538.5010
NGAI SHU KWONGInterim CFO
43100
0.0552%
$18,692.4710
UBS AG10 percent owner
31626
0.0405%
$13,716.206565
<0.0001%
*Gray background shows insiders who have made transactions during last year

IGC Institutional Investors: Active Positions

Increased Positions12+48%346,941+12.13%
Decreased Positions6-24%165,496-5.79%
New Positions6New130,276New
Sold Out Positions2Sold Out140,524Sold Out
Total Postitions31+24%3M+6.35%

IGC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$303.000.77%703,79800%2025-06-30
Geode Capital Management, Llc$303.000.77%703,303+3,289+0.47%2025-06-30
Vanguard Group Inc$278.000.71%645,16600%2025-06-30
Citadel Advisors Llc$117.000.3%270,966+176,495+186.82%2025-06-30
State Street Corp$69.000.18%160,207-5,100-3.08%2025-06-30
Northern Trust Corp$49.000.13%113,40700%2025-06-30
Dearborn Partners Llc$36.000.09%84,40100%2025-06-30
Goldman Sachs Group Inc$28.000.07%65,54100%2025-06-30
Renaissance Technologies Llc$24.000.06%55,025+55,025New2025-06-30
Virtu Financial Llc$20.000.05%46,892+46,892New2025-06-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.